Co-Diagnostics (CODX) Price & Analysis

Compare

1,627 Followers

CODX Stock Chart & Stats

$0.41

-$0.07(-8.42%)

At close: Jan 08 4:00 PM EST

$0.41

-$0.07(-8.42%)

Day’s Range― - ―

52-Week Range$0.23 - $1.55

Previous CloseN/A

Volume146.43K

Average Volume (3M)10.09M

Market Cap

$23.70M

Enterprise Value-$2.38M

Total Cash (Recent Filing)$13.36M

Total Debt (Recent Filing)$1.70M

Price to Earnings (P/E)―

Beta1.53

Next Earnings

Nov 13, 2025

EPS Estimate

-0.16

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.23

Shares Outstanding60,144,855

10 Day Avg. Volume1,334,715

30 Day Avg. Volume10,088,102

Financial Highlights & Ratios

PEG Ratio-0.18

Price to Book (P/B)0.42

Price to Sales (P/S)5.81

P/FCF Ratio-0.76

Enterprise Value/Market Cap-0.10

Enterprise Value/Revenue-2.37

Enterprise Value/Gross Profit-5.99

Enterprise Value/Ebitda0.07

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusHold

Number of Analyst Covering1

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Clinical TrialsManagement expects to initiate clinical evaluations for all tests in the pipeline before the end of 2025.

EarningsNet loss was $7.7M, or ($0.23) per share, less than the estimated loss of $8.3M.

Product DevelopmentThe company is currently training clinical evaluation sites for enhanced COVID-19 test and recruitment of participants may start imminently.

Bears Say

Capital RequirementsCash flows from operating activities were ($8.3M) during 2Q25, indicating the need to raise additional capital in the near term to fund operations.

Commercial RisksFailure to achieve commercial success due to market size, penetration rate, and/or competition is a risk.

Regulatory RisksThere is a risk of failure in clinical evaluations and failure to secure regulatory clearance for the instrument and/or tests in the U.S.

Co-Diagnostics News

Co-Diagnostics selects Maxim Group as financial advisor for CoSara Diagnostics

Co-Diagnostics (CODX) announced that it has engaged Maxim Group as its exclusive financial advisor to assist the Company...

3d ago

CODX

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Getty Images (GETY) 49.86%...

4d ago

IEP

NNE

Co-Diagnostics forms new AI business unit

Co-Diagnostics (CODX) announced the formation of a newly organized, artificial intelligence business unit, led by Chief Technology &...

5d ago

CODX

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Co-Diagnostics (CODX) 108.22% +12.33,...

8d ago

LGO

Co-Diagnostics announces closing of $7M registered direct offering

Co-Diagnostics (CODX) announced the closing of its previously announced offering of 12,727,272 shares of common stock at an...

10d ago

CODX

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Beyond Meat (BYND) 46.53%...

10d ago

BTQ

SLS

Co-Diagnostics announces pricing of $7M registered direct offering

Co-Diagnostics (CODX) announced that it has entered into a securities purchase agreement with several institutional investors for the...

11d ago

CODX

3 Penny Stocks to Watch Now, 10/28/25

Co-Diagnostics, Bio-Key International, and Nauticus Robotics are the 3 Penny Stocks to watch on October 28, 2025, based on TipRanks’ Penny...

12d ago

BYKI

CODX

Co-Diagnostics forms CoMira Diagnostics JV with Arabian Eagle in Saudi Arabia

Co-Diagnostics (CODX) has entered into a definitive agreement with Arabian Eagle, a regional manufacturing and distribution company based...

12d ago

CODX

Co-Diagnostics announces development of sample prep instrument for PoC testing

Co-Diagnostics (CODX) announced the development of a proprietary sample preparation instrument designed to streamline and simplify the workflow...

23d ago

CODX

Co-Diagnostics Announces $7M Securities Purchase Agreement

Co-Diagnostics ( ($CODX) ) has issued an announcement. On October 28, 2025, Co-Diagnostics, Inc. announced a Securities Purchase...

10d ago

CODX

Co-Diagnostics Launches New Equity Distribution Agreement

The latest update is out from Co-Diagnostics ( ($CODX) ). On October 20, 2025, Co-Diagnostics, Inc. entered into...

19d ago

CODX

Co-Diagnostics to Present at Lytham Partners Conference

Co-Diagnostics ( ($CODX) ) has shared an announcement. On September 30, 2025, Co-Diagnostics, Inc. announced its participation in...

1M ago

CODX

Co-Diagnostics Announces $3.8M Securities Purchase Agreement

Co-Diagnostics ( ($CODX) ) has shared an announcement. On September 17, 2025, Co-Diagnostics, Inc. announced a securities purchase...

2M ago

CODX

CODX FAQ

What was Co-Diagnostics Inc’s price range in the past 12 months?

Co-Diagnostics Inc lowest stock price was $0.23 and its highest was $1.55 in the past 12 months.

What is Co-Diagnostics Inc’s market cap?

Co-Diagnostics Inc’s market cap is $23.70M.

When is Co-Diagnostics Inc’s upcoming earnings report date?

Co-Diagnostics Inc’s upcoming earnings report date is Nov 13, 2025 which is in 5 days.

How were Co-Diagnostics Inc’s earnings last quarter?

Co-Diagnostics Inc released its earnings results on Aug 14, 2025. The company reported -$0.23 earnings per share for the quarter, beating the consensus estimate of -$0.25 by $0.02.

Is Co-Diagnostics Inc overvalued?

According to Wall Street analysts Co-Diagnostics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Co-Diagnostics Inc pay dividends?

Co-Diagnostics Inc does not currently pay dividends.

What is Co-Diagnostics Inc’s EPS estimate?

Co-Diagnostics Inc’s EPS estimate is -0.16.

How many shares outstanding does Co-Diagnostics Inc have?

Co-Diagnostics Inc has 60,144,855 shares outstanding.

What happened to Co-Diagnostics Inc’s price movement after its last earnings report?

Co-Diagnostics Inc reported an EPS of -$0.23 in its last earnings report, beating expectations of -$0.25. Following the earnings report the stock price went up 11.538%.

Which hedge fund is a major shareholder of Co-Diagnostics Inc?

Currently, no hedge funds are holding shares in CODX

Company Description

Co-Diagnostics Inc

Co-Diagnostics, Inc. (CODX) is a molecular diagnostics company that develops and manufactures diagnostic tests based on its proprietary CoPrimer technology. The company focuses on the design of tests for infectious diseases, including COVID-19, and offers its products to laboratories, healthcare providers, and other organizations globally. Co-Diagnostics operates primarily in the healthcare sector, utilizing advanced technology to provide accurate and efficient diagnostic solutions.

Co-Diagnostics (CODX) Earnings & Revenues

Historic Earnings Reports

CODX Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Negative

The earnings call highlighted significant advancements in Co-Diagnostics' Co-DX PCR platform development, supported by major grants and upcoming clinical evaluations. However, these positives were overshadowed by a sharp revenue decline and increased losses, indicating financial challenges.View all CODX earnings summaries

CODX Stock 12 Month Forecast

Average Price Target

―

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","-1":"-$1","-0.25":"-$0.25","0.5":"$0.5","1.25":"$1.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">―</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">―</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">―</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.25,0.5,1.25,2],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.46,0.4246153846153846,0.38923076923076927,0.35384615384615387,0.31846153846153846,0.28307692307692306,0.24769230769230768,0.2123076923076923,0.1769230769230769,0.1415384615384615,0.1061538461538461,0.07076923076923075,0.03538461538461535,{"y":null,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.46,0.4246153846153846,0.38923076923076927,0.35384615384615387,0.31846153846153846,0.28307692307692306,0.24769230769230768,0.2123076923076923,0.1769230769230769,0.1415384615384615,0.1061538461538461,0.07076923076923075,0.03538461538461535,{"y":null,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.46,0.4246153846153846,0.38923076923076927,0.35384615384615387,0.31846153846153846,0.28307692307692306,0.24769230769230768,0.2123076923076923,0.1769230769230769,0.1415384615384615,0.1061538461538461,0.07076923076923075,0.03538461538461535,{"y":null,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.05,"date":1717200000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.11,"date":1722470400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.21,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.94,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.75,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.5,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.33,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.36,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.26,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.28,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.25,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.35,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.46,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >